Back to top
more

Dynavax Technologies Corporation (DVAX)

(Delayed Data from NSDQ)

$4.24 USD

4.24
773,018

+0.13 (3.16%)

Updated Oct 17, 2019 04:00 PM ET

After-Market: $4.22 -0.02 (-0.47%) 6:36 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.50%
17.69%
9.28%
4.86%
1.63%
10.50%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

F Value | F Growth | B Momentum | F VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Benjamin Rains

Here's How to Find Top-Ranked Stocks Under $10 to Buy

Here are 5 stocks of the over 30 highly-ranked stocks trading under $10 a share that made it through this week's screen...

NPTN MOBL EGO DVAX CPRX

Zacks Equity Research

Dynavax Technologies Corporation (DVAX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Dynavax Technologies Corporation (DVAX).

DVAX

Zacks Equity Research

Dynavax Technologies (DVAX) Reports Q2 Loss, Tops Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -4.76% and 4.94%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

DVAX

Zacks Equity Research

Dynavax Technologies Sees Hammer Chart Pattern: Time to Buy?

Dynavax Technologies Corporation (DVAX) has been struggling lately, but the selling pressure may be coming to an end soon.

DVAX

Zacks Equity Research

Dynavax (DVAX) to Cut Jobs and Focus on Vaccine Business

Dynavax (DVAX) announces restructuring measures to focus on vaccine business. The CEO of the company will retire on Aug 1, 2019.

ANIK DVAX AGTC AXGT

Zacks Equity Research

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 7.46% and -3.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

DVAX

Zacks Equity Research

Analysts Estimate Dynavax Technologies (DVAX) to Report a Decline in Earnings: What to Look Out for

Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DVAX

Zacks Equity Research

Dynavax Technologies (DVAX) Q3 Earnings Preview: What to Watch Ahead of the Release

Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DVAX

Zacks Equity Research

Dynavax (DVAX) Catches Eye: Stock Jumps 9.8%

Dynavax (DVAX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

AXON DVAX

Zacks Equity Research

Dynavax Technologies (DVAX) Reports Q2 Loss, Lags Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -6.78% and -24.23%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

DVAX

Arpita Dutt

5 of the Best-Performing Biotech Stocks of 2017

With 2017 coming to an end, it is time to take a look at the performance of the biotech sector and some of the best-performing biotech stocks including XOMA (XOMA).

PFE DVAX GILD XOMA

Arpita Dutt

Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer

Regulatory actions and licensing and collaboration agreements were the key highlights this week with companies like Loxo Oncology (LOXO) remaining in the limelight.

VRTX DVAX AMGN ACHN

Zacks Equity Research

Options Traders Expect Huge Moves in Dynavax (DVAX) Stock

Dynavax (DVAX) needs investors to pay close attention to the stock based on moves in the options market lately.

DVAX

Arpita Dutt

Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted

While focus remained on Regeneron's (REGN) Q3 earnings, Dicerna was also in the news related to its collaboration agreement with Boehringer Ingelheim.

VRTX REGN DVAX GILD

Zacks Equity Research

The Zacks Analyst Blog Highlights: Keryx Biopharmaceuticals, Bristol-Myers Squibb, Dynavax Technologies, Heron Therapeutics and Ultragenyx Pharmaceutical

The Zacks Analyst Blog Highlights: Keryx Biopharmaceuticals, Bristol-Myers Squibb, Dynavax Technologies, Heron Therapeutics and Ultragenyx Pharmaceutical

BMY DVAX KERX RARE

Arpita Dutt

5 Biotech and Pharma Stocks with Key FDA Catalysts this November

Here is a look at five biotech and pharma stocks including Dynavax (DVAX) that have an important regulatory event lined up this month.

BMY NVS DVAX GILD

Sweta Killa

Best Sector ETF of Q3 and its Top-Performing Stocks

Inside the top performing stocks of top U.S.-focused ETF of Q3.

BBC DVAX SGMO INSM

Zacks Equity Research

Are Options Traders Betting on a Big Move in Dynavax (DVAX) Stock?

Investors in Dynavax Technologies Corporation (DVAX) need to pay close attention to the stock based on moves in the options market lately.

DVAX

Arpita Dutt

Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data

Regeneron (REGN) and several other biotech companies reported Q2 earnings while FibroGen hit a 52-week high on promising idiopathic pulmonary fibrosis (IPF) data.

ABBV VRTX REGN DVAX

Zacks Equity Research

Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session

Dynavax Technologies Corporation (DVAX) was a big mover last session, as the company saw its shares rise over 11% on the day.

ALXN DVAX

Arpita Dutt

Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote

Companies like Gilead (GILD) topped expectations in the second quarter while Dynavax shot up on a positive FDA advisory panel vote.

ABBV AGIO VRTX DVAX

Zacks Equity Research

Company News For August 1, 2017

Companies in the news are: DVAX,SNI,MDT,CAH,DISC,LH

SNI MDT DVAX DISCA

Megan Sanks

Dynavax (DVAX) Shares Jump 75% after FDA Committee Approval

Dynavax Technologies Corp. (DVAX) shares rocketed 75% in morning trading on Monday after a Food and Drug Administration committee approved the company's hepatitis B vaccination.

DVAX

Zacks Equity Research

Options Traders Expect Huge Moves in Dynavax Technologies (DVAX) Stock

Dynavax Technologies (DVAX) needs Investors to pay close attention to the stock based on moves in the options market lately.

DVAX

Zacks Equity Research

Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6%

Dynavax Technologies Corporation (DVAX) shares rose almost 7% in the last trading session.

DVAX AIMT